The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
150 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,824,219 in first-year total cost, median $79,000.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-5 (O1)]15
- Special Emphasis Panel[ZCA1 SRB-J (O1)]13
- Special Emphasis Panel[ZCA1 SRB-2 (O1)]11
- Special Emphasis Panel[ZCA1 RTRB-U (J1)]10
- Special Emphasis Panel[ZCA1 SRB-8 (J1)]8
Most frequent institutions
- HARVARD SCHOOL OF PUBLIC HEALTH5
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI4
- UNIVERSITY OF COLORADO DENVER4
- UNIVERSITY OF TX MD ANDERSON CAN CTR4
- BAYLOR COLLEGE OF MEDICINE3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Resolving the obesity paradox in kidney cancer"1R03CA212720-01 | ROBINSON, WHITNEY RAGAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $99,286 | ZCA1 |
| 2017 | Understanding causal effects of a treatment on survival in observational studies with unmeasured confounding and an application to effect of PMRT on breast cancer patients1R03CA208387-01A1 | YANG, FAN | UNIVERSITY OF COLORADO DENVER, CO | $96,251 | ZCA1 |
| 2017 | LDL cholesterol and TKI resistance in renal cell carcinoma1R03CA212949-01 | KOLENKO, VLADIMIR M | RESEARCH INST OF FOX CHASE CAN CTR, PA | $91,500 | ZCA1 |
| 2017 | Genes determining sensitivity to oxygen and nutrient deprivation1R03CA205178-01A1 | KANDEL, EUGENE S | ROSWELL PARK CANCER INSTITUTE CORP, NY | $87,050 | ZCA1 |
| 2017 | Molecular basis for the protective function of Mps1 for aneuploid cells1R03CA212867-01 | MEYER, REGIS ERWAN ERNEST ROGER | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $86,667 | ZCA1 |
| 2017 | The role of CAF-1 complex in tumor progression1R03CA212562-01 | BLENIS, JOHN | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $84,750 | ZCA1 |
| 2017 | Assisted Network-based Analysis of Cancer Gene Expression Studies1R03CA216017-01 | MA, SHUANGGE | YALE UNIVERSITY, CT | $83,750 | ZCA1 |
| 2017 | Modeling Mdm2- and 12q amplicon-driven sarcoma1R03CA216466-01 | MANFREDI, JAMES J | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $83,493 | ZCA1 |
| 2017 | Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment1R03CA212924-01 | BENEDICT, CATHERINE | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $82,500 | ZCA1 |
| 2017 | Beta-adrenergic mediated suppression of T cell chemotaxis by cancers1R03CA216016-01 | MULLINS, DAVID W. | DARTMOUTH COLLEGE, NH | $81,000 | ZCA1 |
| 2017 | Engineered precancerous cells and tissues for discovery of lung cancer drivers1R03CA215777-01 | PARK, KWON-SIK | UNIVERSITY OF VIRGINIA, VA | $80,521 | ZCA1 |
| 2017 | Improving dose coverage of tumor periphery in radiotherapy of lung cancer through the use of flattening filter free beams1R03CA211143-01 | VASSILIEV, OLEG | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2017 | Loss of novel end joining factor with dysfunction of BRCA1 contributes to treatment resistance1R03CA212556-01 | TOMIDA, JUNYA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2017 | Novel approaches for studying topoisomerase 2 targeting anti-cancer drugs1R03CA216010-01 | NITISS, JOHN L | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $79,950 | ZCA1 |
| 2017 | Epigenetic regulation of metabolic rerpogramming in pancreatic cancer1R03CA212068-01 | TZATSOS, ALEXANDROS | GEORGE WASHINGTON UNIVERSITY, DC | $79,750 | ZCA1 |
| 2017 | The role of X chromosome inactivation in ovarian cancer1R03CA212127-01 | WINHAM, STACEY J | MAYO CLINIC ROCHESTER, MN | $79,500 | ZCA1 |
| 2017 | Role of mismatch repair in regulating effects of PARP inhibition in Glioblastoma1R03CA201612-01A1 | GUPTA, SHIV KUMAR | MAYO CLINIC ROCHESTER, MN | $79,500 | ZCA1 |
| 2017 | Weight cycling and total and site-specific cancer incidence and mortality1R03CA204825-01A1 | GIOVANNUCCI, EDWARD | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $79,354 | ZCA1 |
| 2017 | Statistical methods for analysis of pooled continuous biomarker data arisen from multiple studies1R03CA212799-01 | WANG, MOLIN | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $79,354 | ZCA1 |
| 2017 | Diet-Associated Gut Microbiome Signatures and Risk of Colon Adenoma1R03CA212558-01 | LI, LI | CASE WESTERN RESERVE UNIVERSITY, OH | $79,250 | ZCA1 |
| 2017 | LMAN1 mutations in colorectal cancer development1R03CA202131-01A1 | ZHANG, BIN | CLEVELAND CLINIC LERNER COM-CWRU, OH | $79,250 | ZCA1 |
| 2017 | Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer1R03CA212816-01 | KAIPPARETTU, BENNY ABRAHAM | BAYLOR COLLEGE OF MEDICINE, TX | $79,250 | ZCA1 |
| 2017 | Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers1R03CA212877-01 | KELLEY, ROBIN KATE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $79,250 | ZCA1 |
| 2017 | Inducible systems for studying liver tumor mainenance in vivo1R03CA208311-01A1 | CHEN, XIN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $79,250 | ZCA1 |
| 2017 | Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma1R03CA215939-01 | HITOMI, MASAHIRO | CLEVELAND CLINIC LERNER COM-CWRU, OH | $79,250 | ZCA1 |
| 2017 | p53 mutation induces constitutive expression of interferon beta, enhancing the resistance of cancer cells to DNA damage1R03CA215941-01 | CHEON, HYEONJOO | CLEVELAND CLINIC LERNER COM-CWRU, OH | $79,250 | ZCA1 |
| 2017 | PPP2R2A tumor suppression haploinsufficiency in prostate cancer1R03CA216134-01 | GRANA, XAVIER | TEMPLE UNIV OF THE COMMONWEALTH, PA | $79,250 | ZCA1 |
| 2017 | NK Cell-Dependent Cancer Immunotherapy with Semi-Synthetic Peptide-Protein Bio-Conjugates1R03CA216136-01 | SABATINO, DAVID | SETON HALL UNIVERSITY, NJ | $79,189 | ZCA1 |
| 2017 | Metformin Supplementation for Ovarian Cancer Prevention: A Prospective Preclinical Study1R03CA208573-01A1 | RAMACHANDRAN, RAMESH | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $78,600 | ZCA1 |
| 2017 | Increased chemoprevention by a mixture of three phytochemicals in prostate cancer1R03CA208221-01A1 | WANG, PIWEN | CHARLES R. DREW UNIVERSITY OF MED & SCI, CA | $78,526 | ZCA1 |
| 2017 | Living with a Smoker, Cross-Domain Health Risk Behaviors, and Obesity1R03CA215947-01 | HOLAHAN, CAROLE K.HOLAHAN, CHARLES J | UNIVERSITY OF TEXAS AT AUSTIN, TX | $78,250 | ZCA1 |
| 2017 | "Defining the interactome for the TET2 tumor suppressor"1R03CA197180-01A1 | HAINES, DALE S. | TEMPLE UNIV OF THE COMMONWEALTH, PA | $78,000 | ZCA1 |
| 2017 | The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia1R03CA215929-01 | GAMERO, ANA M | TEMPLE UNIV OF THE COMMONWEALTH, PA | $78,000 | ZCA1 |
| 2017 | Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu1R03CA212800-01 | HANKINSON, TODD C | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2017 | Impact of age-related changes of the dermal extracellular matrix on skin cancer1R03CA212990-01 | FISHER, GARY JQUAN, TAIHAO | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $77,542 | ZCA1 |
| 2017 | Unphosphorylated STAT recruits HP1 for gene repression1R03CA212727-01 | LI, WILLIS X | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $77,500 | ZCA1 |
| 2017 | Assessing the effect of anti-PD-1/PD-L1 agents on tumoricidal efficacy of secretory TRAIL-armed NK cells1R03CA205267-01A1 | LEE, YONG J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $77,312 | ZCA1 |
| 2017 | Statistical analysis of single cell RNA-sequencing data: detecting dropouts and removing the cell-cycle effect1R03CA212964-01 | LI, JUN | UNIVERSITY OF NOTRE DAME, IN | $77,250 | ZCA1 |
| 2017 | A Field Test of a Group-delivered Enhancing Connections Program: a Partnership Grant with the Cancer Support Community1R03CA212993-01 | LEWIS, FRANCES MARCUS | UNIVERSITY OF WASHINGTON, WA | $77,250 | ZCA1 |
| 2017 | AHCC for the Treatment of HPV Infections to Prevent Cancer1R03CA212935-01 | SMITH, JUDITH A | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $77,000 | ZCA1 |
| 2017 | A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery1R03CA216127-01 | YANG-HARTWICH, YANG | YALE UNIVERSITY, CT | $77,000 | ZCA1 |
| 2017 | Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families1R03CA208494-01A1 | TAINSKY, MICHAEL A | WAYNE STATE UNIVERSITY, MI | $77,000 | ZCA1 |
| 2017 | Bixin-based dietary skin photoprotection and suppression of photocarcinogenesis1R03CA212719-01 | WONDRAK, GEORG T | UNIVERSITY OF ARIZONA, AZ | $76,750 | ZCA1 |
| 2017 | Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma1R03CA216153-01 | SMAS, CYNTHIA M | UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS, OH | $76,750 | ZCA1 |
| 2017 | THE EPIGENETIC ROLE OF THE NOVEL LONG NONCODING RNA, LCAL5, IN LUNG CANCER1R03CA215372-01 | WHITE, NICOLE MARIE | WASHINGTON UNIVERSITY, MO | $76,250 | ZCA1 |
| 2017 | Identification of clonal DNA methylation and chromatin accessibility1R03CA212829-01 | CHOI, JEONG-HYEONSHI, HUIDONG | AUGUSTA UNIVERSITY, GA | $76,000 | ZCA1 |
| 2017 | Analysis of BRCA Testing Patterns Using the Utah Population Database1R03CA212911-01 | KOHLMANN, WENDY K | UNIVERSITY OF UTAH, UT | $75,834 | ZCA1 |
| 2017 | Developing Recycled Colon Bioavailable (r-CB) COXIBs for the Treatment of Familial adenomatous polyposis (FAP)1R03CA212937-01 | GAO, SONG | UNIVERSITY OF HOUSTON, TX | $75,667 | ZCA1 |
| 2017 | Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma1R03CA215940-01 | YUSTEIN, JASON | BAYLOR COLLEGE OF MEDICINE, TX | $75,288 | ZCA1 |
| 2017 | Bax/Bak activation without direct activator BH3-only proteins in cancer cells1R03CA205496-01A1 | LUO, XU | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $75,250 | ZCA1 |
| 2017 | Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma1R03CA212798-01 | AFAQ, FARRUKH | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $74,250 | ZCA1 |
| 2017 | Enabling a new route for the creation of short, diverse peptide libraries through breaking the degeneracy of the genetic code1R03CA216116-01 | HARTMAN, MATTHEW C | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $72,838 | ZCA1 |
| 2017 | the role of EZH2 in neuroendocrine prostate cancer1R03CA212567-01 | YU, XIUPING | LOUISIANA STATE UNIV HSC SHREVEPORT, LA | $72,500 | ZCA1 |
| 2017 | Microdevice-Armed Macrophage For Treating Cancer1R03CA202334-01A1 | GUAN, JINGJIAOREN, YI | FLORIDA STATE UNIVERSITY, FL | $70,668 | ZCA1 |
| 2017 | Sirolimus Delivery from Esophageal Stents to Prevent Scarring after Mucosectomy1R03CA204890-01A1 | VON RECUM, HORST A. | CASE WESTERN RESERVE UNIVERSITY, OH | $70,246 | ZCA1 |
| 2017 | Engineering Viruses for Cancer Therapy1R03CA216179-01 | PENG, CHING-AN | UNIVERSITY OF IDAHO, ID | $68,748 | ZCA1 |
| 2017 | PARP-1-dependent transcription in progression and maintenance of renal cell carcinoma1R03CA212566-01 | TULIN, ALEXEI V | RESEARCH INST OF FOX CHASE CAN CTR, PA | $63,272 | ZCA1 |
| 2017 | Colorectal Cancer: Characterization of a new Cre-LoxP Model1R03CA216160-01 | KHARE, SHARAD | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $60,790 | ZCA1 |
| 2016 | Analyzing Complex Cancer Studies With Skewed Responses1R03CA205018-01 | LIPSITZ, STUART R. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $102,674 | ZCA1 |
| 2016 | Wired for Colorectal Cancer Screening: An mHealth Intervention1R03CA198580-01A1 | DAVIS, STACY N | RBHS-SCHOOL OF PUBLIC HEALTH, NJ | $97,869 | ZCA1 |
| 2016 | The Obesity Paradox in Renal Cell Carcinoma1R03CA195098-01A1 | PRESTON, MARK ARTHURWILSON, KATHRYN M. | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $96,159 | ZCA1 |
| 2016 | Refining and testing the electronic Social Network Assessment Program (eSNAP)1R03CA201684-01 | REBLIN, MAIJA | H. LEE MOFFITT CANCER CTR & RES INST, FL | $94,966 | ZCA1 |
| 2016 | Cognitive and Psychosocial Functioning of Children Treated for Retinoblastoma1R03CA201540-01 | WILLARD, VICTORIA W. | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $89,312 | ZCA1 |
| 2016 | Communicate and LEarn About youR Variant of Uncertain Significance (CLEAR VUS)1R03CA194643-01A1 | SCHERR, COURTNEY LYNAM | NORTHWESTERN UNIVERSITY, IL | $87,900 | ZCA1 |
| 2016 | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors1R03CA201459-01 | RECKLITIS, CHRISTOPHER JOHN | DANA-FARBER CANCER INST, MA | $87,500 | ZCA1 |
| 2016 | Community-level Geographic Factors and HPV Vaccination in the U.S.1R03CA202566-01 | KEPKA, DEANNA LEE | UNIVERSITY OF UTAH, UT | $86,146 | ZCA1 |
| 2016 | Genomic markers predicting tumor response to cytotoxic chemotherapy1R03CA202354-01 | DEMANT, PETER | ROSWELL PARK CANCER INSTITUTE CORP, NY | $85,750 | ZCA1 |
| 2016 | Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for Chinese Taxi Drivers1R03CA202515-01A1 | LENG, JENNIFER CF | SLOAN-KETTERING INST CAN RESEARCH, NY | $85,700 | ZCA1 |
| 2016 | Long-term trends in breast cancer DNA copy number alterations & disparities1R03CA193078-01A1 | KRIEGER, NANCY | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $85,312 | ZCA1 |
| 2016 | Sun Protection Barriers and Facilitators Scale (SP-BFS) for Latinos1R03CA195039-01A1 | SANTIAGO-RIVAS, MARIMER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2016 | Defining Monoclonal Gammopathy of Unknown Significance in Automated Health Data1R03CA199383-01A1 | EPSTEIN, MARA MEYER | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $83,750 | ZCA1 |
| 2016 | Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors1R03CA208510-01 | RUSSELL, STEWART | DARTMOUTH COLLEGE, NH | $81,000 | ZCA1 |
| 2016 | Identifying leptomeningeal metastasis from breast cancer utilizing a novel immunocytochemical microfluidic device1R03CA208547-01 | KALINSKY, KEVIN MICHAEL | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $80,000 | ZCA1 |
| 2016 | Inositol-trisphosphate 3-kinase and colorectal cancer cell adhesion1R03CA182132-01A1 | GASPERS, LAWRENCE D | RBHS-NEW JERSEY MEDICAL SCHOOL, NJ | $79,500 | ZCA1 |
| 2016 | Enhancing at-Risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer1R03CA191543-01A1 | HURTADO DE MENDOZA CASAUS, ALEJANDRASHEPPARD, VANESSA B | GEORGETOWN UNIVERSITY, DC | $79,305 | ZCA1 |
| 2016 | Allogeneic antibody therapy for malignant mesothelioma1R03CA205713-01 | BURT, BRYAN MICHAEL | BAYLOR COLLEGE OF MEDICINE, TX | $79,250 | ZCA1 |
| 2016 | Separating the function of RAD51 in homologous recombination and replication1R03CA205518-01 | BISHOP, DOUGLAS K | UNIVERSITY OF CHICAGO, IL | $79,000 | ZCA1 |
| 2016 | Expression and purification of human HOPS complex for biochemical reconstitution of autophagosome-lysosome fusion1R03CA201724-01A1 | STROUPE, CHRISTOPHER | UNIVERSITY OF VIRGINIA, VA | $79,000 | ZCA1 |
| 2016 | Effect of different MRgHIFU approaches on anti-tumor responses1R03CA201918-01 | JANSSEN, EDITH M | CINCINNATI CHILDRENS HOSP MED CTR, OH | $78,000 | ZCA1 |
| 2016 | Deletion of Arid1a and Kras as a Model of Endometriosis-Associated Ovarian Cancer1R03CA191527-01A1 | HAWKINS, SHANNON MICHELLE | INDIANA UNIVERSITY INDIANAPOLIS, IN | $78,000 | ZCA1 |
| 2016 | Genome-edited uveal melanoma cell lines for investigating constitutively active GNAQ and GNA111R03CA202316-01 | WEDEGAERTNER, PHILIP B | THOMAS JEFFERSON UNIVERSITY, PA | $78,000 | ZCA1 |
| 2016 | Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-71R03CA195250-01A1 | NAKSHATRI, HARIKRISHNA | INDIANA UNIVERSITY INDIANAPOLIS, IN | $78,000 | ZCA1 |
| 2016 | Molecular Mechanisms of Chromosomal Segregation by Epigenetic Regulators1R03CA191443-01A1 | REN, XIAOJUN | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2016 | p53 in Melanomagenesis1R03CA191937-01A1 | TERZIAN, TAMARA G | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | ZCA1 |
| 2016 | Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention1R03CA186176-01A1 | LIU, SHUJUN | UNIVERSITY OF MINNESOTA, MN | $77,500 | ZCA1 |
| 2016 | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer Caregivers1R03CA208560-01 | NIGHTINGALE, CHANDYLEN LENAE | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $77,500 | ZCA1 |
| 2016 | Time to first cigarette and early detection in the National Lung Screening Trial1R03CA201951-01 | MUSCAT, JOSHUA EZHU, JUNJIA | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $77,350 | ZCA1 |
| 2016 | Obstructive Sleep Apnea and Cancer Burden: Impact of Apnea Severity and Treatment1R03CA201806-01A1 | PHIPPS, AMANDA IRENE | UNIVERSITY OF WASHINGTON, WA | $77,271 | ZCA1 |
| 2016 | Parenting in the Face of Cancer: Non-Ill Sibling and Parent Relationships1R03CA186910-01A1 | WALKER, AMY J | UNIVERSITY OF WASHINGTON, WA | $77,250 | ZCA1 |
| 2016 | Optogenetic control of vagal afferent signaling in chemotherapy-induced nausea and emesis1R03CA201962-01A1 | HORN, CHARLES CHRISTOPHER | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $77,125 | ZCA1 |
| 2016 | The Psychoneuroimmunological Consequences of Cancer and Cancer Survivorship1R03CA201681-01 | PYTER, LEAH M | OHIO STATE UNIVERSITY, OH | $77,000 | ZCA1 |
| 2016 | Multiplex 'Conditional' Mice for Rapid and Affordable Pre-clinical Testing1R03CA201502-01 | MORIARITY, BRANDEN S | UNIVERSITY OF MINNESOTA, MN | $76,000 | ZCA1 |
| 2016 | Discovery and Pathogenetic Significance of Chromosome Translocations in Angiosarcom1R03CA191713-01A1 | MODIANO, JAIME F. | UNIVERSITY OF MINNESOTA, MN | $76,000 | ZCA1 |
| 2016 | MYC/miR-18a-5p/HIF1A regulatory network confers drug resistance to breast cancer1R03CA197206-01A1 | FAN, MEIYUN | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $76,000 | ZCA1 |
| 2016 | Effects of psychological stress on DNA damage and repair in healthy BRCA1+ women1R03CA201982-01 | BOVBJERG, DANA H.JENKINS, FRANK J | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $75,630 | ZCA1 |
| 2016 | The Natural History of Untreated Breast Cancer1R03CA201821-01 | HILL, DEIRDRE | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $75,604 | ZCA1 |
| 2016 | A Novel RhoG Protein Interaction Network in Invadopodia1R03CA197227-01A1 | GARCIA-MATA, RAFAEL | UNIVERSITY OF TOLEDO, OH | $75,550 | ZCA1 |
| 2016 | Adolescent tanning and social media1R03CA201953-01 | MORENO, MEGAN A. | SEATTLE CHILDREN'S HOSPITAL, WA | $75,000 | ZCA1 |
| 2016 | Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma1R03CA201988-01 | TSAI, ROBERT Y | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $74,250 | ZCA1 |
| 2016 | Development of a mouse model of pediatric high-grade gliomas1R03CA205311-01 | XIE, ZHIGANG | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $74,250 | ZCA1 |
| 2016 | Impact of social and built environments on health-related quality of life for cancer survivors1R03CA202192-01 | SHARIFF-MARCO, SALMA | CANCER PREVENTION INSTIT OF CALIFORNIA, CA | $72,530 | ZCA1 |
| 2016 | Synthetic lethality in VHL tumor suppressor null tumors1R03CA202563-01 | RAZORENOVA, OLGA V | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $71,074 | ZCA1 |
| 2016 | Development of multifunctional biodegradable drug-loaded polymer stents for inoperable esophageal malignancies1R03CA201960-01 | KANG, YUNQING | FLORIDA ATLANTIC UNIVERSITY, FL | $70,962 | ZCA1 |
| 2016 | Target Identification and Validation to Overcome Antiestrogen Resistance in ER+ Breast Cancer1R03CA202427-01 | CHERIYATH, VENUGOPALAN | EAST TEXAS A&M UNIVERSITY, TX | $68,000 | ZCA1 |
| 2016 | Methionine metabolism in esophageal adenocarcinoma carcinogenesis1R03CA195660-01A1 | SHRUBSOLE, MARTHA J. | VANDERBILT UNIVERSITY, TN | $4,636 | ZCA1 |
| 2015 | Daily Cognitive Functioning Among Cancer Survivors1R03CA191712-01A1 | SCOTT, STACEY BETHSMALL, BRENT JOHN | UNIVERSITY OF SOUTH FLORIDA, FL | $97,363 | ZCA1 |
| 2015 | Discovering the spectrum of natural somatic mosaicism in human skin fibroblasts1R03CA191421-01A1 | ABYZOV, ALEXEJ | MAYO CLINIC ROCHESTER, MN | $96,085 | ZCA1 |
| 2015 | Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors1R03CA184306-01A1 | LUTGENDORF, SUSAN K | UNIVERSITY OF IOWA, IA | $92,196 | ZCA1 |
| 2015 | Small circular DNA as a signature of defects in DNA replication control1R03CA188111-01A1 | TANAKA, HISASHI | CEDARS-SINAI MEDICAL CENTER, CA | $87,500 | ZCA1 |
| 2015 | Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis1R03CA194795-01 | ZENG, HUIYAN | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $87,000 | ZCA1 |
| 2015 | Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention1R03CA195143-01 | ROY, HEMANT K. | BOSTON MEDICAL CENTER, MA | $87,000 | ZCA1 |
| 2015 | Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis1R03CA191463-01A1 | ZENG, HUIYAN | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $87,000 | ZCA1 |
| 2015 | Organ specific macrophages and the regulation of disseminated tumor cell fate1R03CA191430-01 | AGUIRRE-GHISO, JULIO A. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2015 | Secondary analysis of Human Mammary Tumor Virus (HMTV) in breast cancer.1R03CA186919-01A1 | MELANA, STELLA MARIS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $84,750 | ZCA1 |
| 2015 | Measure Development for Prediction of E-cigarette Initiation1R03CA195124-01 | HARRELL, PAUL TRUMAN | EASTERN VIRGINIA MEDICAL SCHOOL, VA | $84,472 | ZCA1 |
| 2015 | Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response1R03CA197539-01 | PIDALA, JOSEPH A | H. LEE MOFFITT CANCER CTR & RES INST, FL | $84,250 | ZCA1 |
| 2015 | Development of a Novel Assay to Measure DSB Repair at Endogenous Loci in Cells1R03CA194967-01 | BINDRA, RANJIT | YALE UNIVERSITY, CT | $83,250 | ZCA1 |
| 2015 | Generation of a novel fusion protein to redirect macrophage differentiation following radiation therapy.1R03CA198208-01 | CRITTENDEN, MARKA | PROVIDENCE PORTLAND MEDICAL CENTER, OR | $82,500 | ZCA1 |
| 2015 | Epithelial-stromal cross-talk in esophageal inflammation and carcinogenesis.1R03CA198692-01 | SHAKER, ANISA | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $82,500 | ZCA1 |
| 2015 | Murine Models on SALL4 in Hepatocellular Carcinoma1R03CA184531-01A1 | CHAI, LI | BRIGHAM AND WOMEN'S HOSPITAL, MA | $81,724 | ZCA1 |
| 2015 | Using Behavioral Economics to Promote Exercise among Inactive Overweight Adults1R03CA188473-01A1 | GALARRAGA, OMARWILLIAMS, DAVID M | BROWN UNIVERSITY, RI | $81,250 | ZCA1 |
| 2015 | Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus1R03CA186218-01A1 | ABRAMS, JULIAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $81,186 | ZCA1 |
| 2015 | Combinational Therapy of Melanoma using T Cells and site-specific Immunomodulators1R03CA188418-01A1 | MULLINS, DAVID W. | DARTMOUTH COLLEGE, NH | $81,000 | ZCA1 |
| 2015 | Specific Molecular Imaging Agents for Clear Cell Renal Cell Carcinoma Diagnosis1R03CA197470-01 | YANG, XING | JOHNS HOPKINS UNIVERSITY, MD | $81,000 | ZCA1 |
| 2015 | Early life risk factors and risk of colorectal neoplasia1R03CA197879-01 | WU, KANA | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $80,750 | ZCA1 |
| 2015 | Machine Learning Comparison of Brain Anatomy in Cancer and Alzheimer's Disease1R03CA191559-01 | KESLER, SHELLI R | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2015 | Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation1R03CA188162-01A1 | HUTCHESON, KATHERINE ARNOLD | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2015 | Optimization of radiofrequency ablation with electrically conductive particles1R03CA191978-01 | KIM, CHARLES Y | DUKE UNIVERSITY, NC | $79,500 | ZCA1 |
| 2015 | A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia1R03CA191983-01A1 | LAVAU, CATHERINE P | DUKE UNIVERSITY, NC | $79,500 | ZCA1 |
| 2015 | THE ROLE OF MALT1 IN MELANOMA GROWTH AND METASTASIS1R03CA188619-01A1 | ZHANG, JENNIFER YUNYAN | DUKE UNIVERSITY, NC | $79,500 | ZCA1 |
| 2015 | A chemopreventive approach of targeting breast cancer stem cells1R03CA198614-01 | DIMRI, MANJARI | GEORGE WASHINGTON UNIVERSITY, DC | $79,250 | ZCA1 |
| 2015 | Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer1R03CA184394-01A1 | LU, XIULING | UNIVERSITY OF CONNECTICUT STORRS, CT | $79,000 | ZCA1 |
| 2015 | Mouse Model of Diet-Enduced Endometrial Cancer1R03CA188459-01A1 | HOEHN, KYLE LEESLACK-DAVIS, JILL | UNIVERSITY OF VIRGINIA, VA | $79,000 | ZCA1 |
| 2015 | A novel combination approach for pancreatic cancer prevention1R03CA181727-01A1 | MACKENZIE, GERARDO GUILLERMO | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $79,000 | ZCA1 |
| 2015 | Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer1R03CA198822-01 | SYED, VIQAR | HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD | $77,878 | ZCA1 |
| 2015 | A la carte 2D artificial antigen presenting system mimicking supramolecular patterns in the natural immunological synapse for precise functional conditioning of tumor-specific T cells1R03CA191952-01 | WEN, FEI | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $77,646 | ZCA1 |
| 2015 | Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes1R03CA191447-01A1 | WALDRON, LEVI | HUNTER COLLEGE, NY | $77,583 | ZCA1 |
| 2015 | HILPDA and lipid metabolism in colorectal cancer1R03CA191653-01 | PAPANDREOU, IOANNA | OHIO STATE UNIVERSITY, OH | $77,000 | ZCA1 |
| 2015 | E-cigarette understanding and use among a diverse sample of ethnic minority adolescents1R03CA198258-01 | COWGILL, BURTON | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $77,000 | ZCA1 |
| 2015 | Nonverbal communication of patient and physician racial attitudes and its effect on cancer treatment disparities1R03CA195147-01 | HAMEL, LAUREN M. | WAYNE STATE UNIVERSITY, MI | $76,375 | ZCA1 |
| 2015 | The role of Sirt2 in haptocarcinogenesis1R03CA195183-01 | QIU, WEI | LOYOLA UNIVERSITY CHICAGO, IL | $75,500 | ZCA1 |
| 2015 | The role of Sin1 in colorectal cancer progression1R03CA187839-01A1 | YANG, HSIN-SHENG | UNIVERSITY OF KENTUCKY, KY | $75,188 | ZCA1 |
| 2015 | Targeted Inhibition of EGFR Dimerization1R03CA188439-01A1 | KENNEDY, EILEEN J | UNIVERSITY OF GEORGIA, GA | $75,000 | ZCA1 |
| 2015 | Role of Piceatannol in Cancer Cachexia1R03CA184544-01A1 | KIM, KEE-HONG | PURDUE UNIVERSITY, IN | $74,653 | ZCA1 |
| 2015 | Bisphosphonate use and Lung Cancer Incidence and Mortality in Elderly Women1R03CA184327-01A1 | TAO, MENGHUA | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $73,000 | ZCA1 |
| 2015 | Myelodysplastic Syndrome Target Identification and Validation1R03CA198630-01 | CHERIYATH, VENUGOPALAN | EAST TEXAS A&M UNIVERSITY, TX | $68,000 | ZCA1 |
| 2015 | Structured illumination multispectral fluorescence lifetime microendoscopy to detect oral premalignancies1R03CA191860-01 | MALIK, BILAL | TEXAS ENGINEERING EXPERIMENT STATION, TX | $65,726 | ZCA1 |
| 2015 | Genomic and transcriptomic characterization of atypical carcinoids of the lung1R03CA195253-01 | MCKAY, JAMES DOWLING | INTERNATIONAL AGENCY FOR RES ON CANCER | $56,500 | ZCA1 |
| 2015 | Persistent SIX2 expression as a first hit mechanism in Wilms tumorigenesis1R03CA182063-01A1 | LOVVORN, HAROLD NEWTON | VANDERBILT UNIVERSITY, TN | $44,623 | ZCA1 |
| 2014 | Monitoring Photo-immunotherapy using Multi-channel Multi-modal Imaging Needles1R03CA176027-01A1 | CHEN, YU | UNIV OF MARYLAND, COLLEGE PARK, MD | $76,000 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.